Research Paper Volume 12, Issue 20 pp 20085—20094

Effect of ticagrelor versus clopidogrel on platelet reactivity measured by thrombelastography in patients with minor stroke or TIA

Figure 1. Proportion of HOPR stratified by dual antiplatelet therapy and CYP2C19 loss-of-function carrier status at 90±7 days. HOPR indicates high on-treatment platelet reactivity; ADP, adenosine diphosphate.